Intestinal Diseases (Diseases, Intestinal)

Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
Also Known As:
Diseases, Intestinal; Disease, Intestinal; Intestinal Disease
Networked: 773 relevant articles (31 outcomes, 63 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Crohn Disease (Crohn's Disease)
2. Infection
3. Ulcerative Colitis
4. Colitis
5. Colorectal Neoplasms (Colorectal Cancer)


1. Turner, Jerrold R: 4 articles (10/2006 - 07/2002)
2. McClane, Bruce A: 3 articles (11/2014 - 01/2010)
3. Gearry, Richard B: 3 articles (06/2014 - 08/2008)
4. Wang, Fengjun: 3 articles (01/2013 - 10/2006)
5. Williams, D A: 3 articles (03/2011 - 02/2000)
6. Yazbeck, Roger: 3 articles (12/2010 - 04/2009)
7. Flint, Harry J: 2 articles (01/2016 - 04/2012)
8. Duncan, Sylvia H: 2 articles (01/2016 - 04/2012)
9. Goda, Taro: 2 articles (08/2015 - 02/2013)
10. Nakayama, Masahiro: 2 articles (08/2015 - 02/2013)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Intestinal Diseases:
1. Messenger RNA (mRNA)IBA
2. Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
3. Leukocyte L1 Antigen Complex (Calgranulin)IBA
4. Immunoglobulin G (IgG)IBA
09/01/1980 - "The preservation of the biological activity of IgG in the digestive secretions of adults receiving immune colostrum orally indicates the expediency of further studies in the field of passive enteral immunization for the prevention and treatment of acute intestinal diseases."
05/01/1976 - "A determination was made of the immunoglobulin G, M and A concentration in the blood serum of women suffering from dysentery and other acute intestinal diseases, those who sustained the disease and healthy persons (259 in all). "
03/01/1984 - "This IgA-IgG intestinal disease inducible in BN rats may provide a model for the study of alterations of the secretory IgA system, as well as for testing the possibility that abnormal deposits IgA-IgG in the intestinal structures are associated with local functional changes."
11/01/1998 - "Small intestinal histology, IgA anti-endomysial and IgG anti-gliadin antibody tests were performed on 441 unselected, consecutive patients under investigation for small intestinal disease. "
04/01/2005 - "This review offers detailed and comprehensive information about IgY-technology, including: a) possibilities for hen keeping in accordance with the Three Rs principles; b) new insights into the IgY transfer mechanism from blood to yolk as a biological basis for the technology; c) the comparative characteristics of IgY Abs and IgG Abs; d) the high efficacy of the technique, in view of the extraordinary amount of IgY Ab produced by one hen in one year (between 20 g and 40 g IgY in total); e) comparisons between the efficacies of IgY Abs and IgG Abs (rabbit, sheep, mouse) in several immunological assays; f) immunisation protocols, as well as the most commonly used IgY-extraction procedures; g) new possibilities for application in human and veterinary medicine, including strategies for the treatment of Helicobacter pylori infection or fatal intestinal diseases in children, particularly in poor countries, for reducing the use of antibiotics, and, in Asia and South America, for producing Abs against snake, spider and scorpion venoms; and h) the use of IgY Abs in various fields of research, also taking into consideration recent developments in South America (particularly Argentina and Cuba) and in Asia."
5. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
6. Proteins (Proteins, Gene)IBA
7. PeptidesIBA
8. C-Reactive ProteinIBA
05/01/1958 - "[C reactive protein in infants with intestinal diseases]."
09/15/2004 - "The negative predictive value of a single calprotectin result below 60 microg/g of stool was 100% compared with 91% each for erythrocyte sedimentation rate > 10 mm and C-reactive protein > 6 mg/L and 84% for a combination of erythrocyte sedimentation rate and C-reactive protein in predicting absence of organic intestinal disease. "
08/01/2002 - "The aim of this study was to assess the sensitivity, specificity, and odds ratios (ORs) of fecal calprotectin, small intestinal permeability, Rome I criteria, and laboratory markers of inflammation (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], blood count) in distinguishing organic from nonorganic intestinal disease. "
01/01/1995 - "Total sialic acid (TSA), C-reactive protein (CRP); alpha 1 acid glycoprotein (alpha 1-AG), and beta 2-microglobulin were determined in 84 patients affected by non-malignant intestinal diseases, Crohn's disease (CD) and ulcerative colitis (UC), active and in remission; non-ulcerative proctosigmoiditis; diverticulosis; diverticulitis (ie, inflammatory complication of diverticulosis). "
01/01/2015 - "Serum concentrations of inflammatory markers (i.e., C-reactive protein [CRP], calprotectin [CP], and S100A12), hyaluronic acid (HA, a marker for cutaneous mucinosis), and analytes commonly altered in chronic intestinal diseases (i.e., albumin, zinc, alpha1-proteinease inhibitor [α1PI], immunoglobulin [Ig]A, and IgM) were compared between Shar-Peis with hypocobalaminemia and Shar-Peis with normocobalaminemia. "
9. RNA (Ribonucleic Acid)IBA
10. Glucagon-Like Peptide 1 (GLP 1)IBA

Therapies and Procedures

1. Transplantation (Transplant Recipients)
2. Therapeutics
3. Total Parenteral Nutrition
4. Aftercare (After-Treatment)
5. Intravenous Infusions